The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Roberto Vargas lab explores genetic factors that make endometrial carcinoma cells resistant to radiation.
Learn MoreThe Jaroslaw Maciejewski lab studies the pathophysiology of bone marrow failure syndromes, including myelodysplastic syndromes.
Learn MoreThe Valeria Visconte lab studies the genetic basis of myelodysplastic syndrome, a blood disorder, to develop new cures for patients.
Learn MorePrecision cancer medicine is the goal of a new multidisciplinary study, led by Dr. Tim Chan, examining radiation therapy combined with targeted therapy
The program, which has funded 21 research teams since 2015, has a proven record of supporting projects that go on to attract large external grants.
Latest novel finding adds to list of cancers associated with the HSD3B1 gene; clinical and research teams investigating potential connections.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers